Viewing Study NCT01660334


Ignite Creation Date: 2025-12-25 @ 2:32 AM
Ignite Modification Date: 2026-01-09 @ 5:57 AM
Study NCT ID: NCT01660334
Status: COMPLETED
Last Update Posted: 2013-12-17
First Post: 2012-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)
Sponsor: Pfizer
Organization:

Study Overview

Official Title: Special Investigation of Vfend on Scedosporisis
Status: COMPLETED
Status Verified Date: 2013-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To collect the efficacy and safety information of voriconazole related to their appropriate use in daily practice.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: